Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kitahara

Showing results (311-320 of 327) with videos related to

Pageof 33
Sort By:
Nihon Jibiinkoka Gakkai Kaiho|February 20, 1999
[Clinical features in patients with delayed endolymphatic hydrops]N Takeda, I Koizuka, S Nishiike, et al.
British Journal of Cancer|January 31, 2003
Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagusK Kaneko, H Ito, K Konishi, et al.
Pediatric Research|April 15, 1999
Central motor reorganization in cerebral palsy patients with bilateral cerebral lesionsY Maegaki, Y Maeoka, S Ishii, et al.
Bone Marrow Transplantation|April 16, 2014
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignanciesM Gotoh, S Yoshizawa, S Katagiri, et al.
Igaku Kenkyu. Acta Medica|September 1, 1979
[Diseases treated at our clinic in south Iran (author's transl)]Y Otsuji, T Maeda, R Harada, et al.
Nephron|January 1, 1997
Relapsing membranous nephropathy with a good response to steroid therapyY Tsukada, S Yano, T Tanaka, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|May 1, 1983
[Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects]M Shimoyama, H Yamada, T Kitahara, et al.
Clinical and Experimental Dermatology|May 28, 2020
Reduced induction of human β-defensins is involved in the pathological mechanism of cutaneous adverse effects caused by epidermal growth factor receptor monoclonal antibodiesR Ommori, Y Nakamura, F Miyagawa, et al.
Oncology|January 14, 1999
A phase II study of concomitant chemoradiotherapy for laryngeal carcinoma using carboplatinT Nishioka, H Shirato, S Fukuda, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
Neurotropic pyrimidine heterocyclic compounds. II. Effects of novel neurotropic pyrimidine derivatives on astrocytic morphological differentiationY Koyama, A Awaya, N Ishikawa, et al.
Pageof 33

Showing results (311-320 of 327) with videos related to

Sort By:
Pageof 33
Nihon Jibiinkoka Gakkai Kaiho|February 20, 1999
[Clinical features in patients with delayed endolymphatic hydrops]N Takeda, I Koizuka, S Nishiike, et al.
British Journal of Cancer|January 31, 2003
Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagusK Kaneko, H Ito, K Konishi, et al.
Pediatric Research|April 15, 1999
Central motor reorganization in cerebral palsy patients with bilateral cerebral lesionsY Maegaki, Y Maeoka, S Ishii, et al.
Bone Marrow Transplantation|April 16, 2014
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignanciesM Gotoh, S Yoshizawa, S Katagiri, et al.
Igaku Kenkyu. Acta Medica|September 1, 1979
[Diseases treated at our clinic in south Iran (author's transl)]Y Otsuji, T Maeda, R Harada, et al.
Nephron|January 1, 1997
Relapsing membranous nephropathy with a good response to steroid therapyY Tsukada, S Yano, T Tanaka, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|May 1, 1983
[Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects]M Shimoyama, H Yamada, T Kitahara, et al.
Clinical and Experimental Dermatology|May 28, 2020
Reduced induction of human β-defensins is involved in the pathological mechanism of cutaneous adverse effects caused by epidermal growth factor receptor monoclonal antibodiesR Ommori, Y Nakamura, F Miyagawa, et al.
Oncology|January 14, 1999
A phase II study of concomitant chemoradiotherapy for laryngeal carcinoma using carboplatinT Nishioka, H Shirato, S Fukuda, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
Neurotropic pyrimidine heterocyclic compounds. II. Effects of novel neurotropic pyrimidine derivatives on astrocytic morphological differentiationY Koyama, A Awaya, N Ishikawa, et al.
Pageof 33